Evidence map›Paper›PMID 40761653›Full record

ArticleERJ open research2025

Development and external validation of a model for lung transplantation-free survival prediction of primary Sjögren syndrome-associated interstitial lung disease: a prospective cohort study.

Wenyan Meng, Xinran Zhang, Shu Zhang, Bingbing Xie, Yanhong Ren, Shiyao Wang, Jing Geng, Xiaojuan Guo, Min Liu, Sheng Xie and 3 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wenyan MengChina-Japan Friendship Hospital, Capital Medical University, Beijing, China.ORCID https://orcid.org/0009-0001-7846-1857
Xinran ZhangNational Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Shu ZhangDepartment of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Bingbing XieNational Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Yanhong RenNational Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Shiyao WangNational Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-1066-4850
Jing GengNational Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Xiaojuan GuoDepartment of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Min LiuDepartment of Radiology, China-Japan Friendship Hospital, Beijing, China.
Sheng XieDepartment of Radiology, China-Japan Friendship Hospital, Beijing, China.
Ling ZhaoDepartment of Pathology, China-Japan Friendship Hospital, Beijing, China.
Chen WangChina-Japan Friendship Hospital, Capital Medical University, Beijing, China.
Huaping DaiChina-Japan Friendship Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Primary Sjögren syndrome-associated interstitial lung disease (pSS-ILD) patients have a worse prognosis than pSS patients without pulmonary involvement. This study aims to establish a prediction nomogram for early prediction of lung transplantation (LTx)-free survival in pSS-ILD patients. Methods: The training cohort comprised 260 patients from China-Japan Friendship Hospital between 1 January 2016 and 30 June 2022, while the external validation cohort consisted of 135 patients from Beijing Chaoyang Hospital between 1 January 2007 and 31 December 2012. Univariable Cox regression analysis and least absolute shrinkage and selection operator were employed for variable selection, and a nomogram model was developed to predict the 1-, 3- and 5-year LTx-free survival. Discrimination and calibration of the nomogram were assessed using the concordance index (C-index), area under the curve, calibration curve and decision curve analysis. Results: Multivariable Cox regression demonstrated that elevated age, oxygenation index, carbohydrate antigen 125 and fibrosis score were independent risk factors for LTx-free survival in pSS-ILD patients. The C-index values for the training and validation cohorts were 0.812 and 0.809, respectively. The 1-, 3- and 5-year AUC values for the training cohort were 0.781, 0.874 and 0.909, respectively, while those for the validation cohort were 0.793, 0.826 and 0.863. The bias-corrected curve was close to the ideal curve and revealed a strong consistency between predicted and observed outcomes. Conclusions: We developed a nomogram capable of predicting the LTx-free survival probability at 1, 3 and 5 years in pSS-ILD patients. This model has the potential to be a useful tool for prediction of death or LTx in pSS-ILD.

Identifiers

PMID40761653
PMCPMC12320109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.